Calliditas Therapeutics AB (publ) (STO: CALTX)

STO: CALTX Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	797.28	973.73	1,249	955.51	996.3	753.54
Cash & Short-Term Investments	797.28	973.73	1,249	955.51	996.3	753.54
Cash Growth	-7.95%	-22.04%	30.73%	-4.09%	32.22%	16.62%
Accounts Receivable	222.59	180.89	78.7	-	-	46.59
Other Receivables	-	7.3	2.29	-	-	-
Receivables	222.59	188.19	80.99	-	-	46.59
Inventory	40.16	20.43	3.65	0.89	-	-
Prepaid Expenses	94.44	33.94	23	17.14	17.11	18.29
Other Current Assets	-	58.86	55.47	39.23	23.44	2.72
Total Current Assets	1,154	1,275	1,412	1,013	1,037	821.13
Property, Plant & Equipment	59.36	54.24	31.92	39.61	5.41	6.06
Long-Term Investments	-	-	-	-	-	0
Goodwill	47.81	48.58	45.78	37.23	37.99	-
Other Intangible Assets	423.86	430.75	438.06	362.19	380.84	16.07
Long-Term Deferred Tax Assets	34.51	26.32	13.8	4.2	0.6	-
Other Long-Term Assets	27.21	24.2	11.21	3.92	2.23	1.94
Total Assets	1,747	1,859	1,953	1,460	1,464	845.2
Accounts Payable	151.02	100.56	160.4	67.97	53.83	24.38
Accrued Expenses	252.14	280.63	136.45	50.17	41.39	24.64
Current Portion of Leases	-	12.54	10.37	9.59	3.91	2.49
Current Income Taxes Payable	-	6.17	5.68	1.22	0.52	0.08
Current Unearned Revenue	-	-	-	3.39	-	0.87
Other Current Liabilities	26.62	7.25	12.32	3.11	5.98	0.91
Total Current Liabilities	429.78	407.14	325.23	135.45	105.62	53.37
Long-Term Debt	982.49	939.51	713.03	189.16	-	-
Long-Term Leases	25.79	27.09	15.79	24.05	0.88	3.58
Long-Term Deferred Tax Liabilities	36.7	41.64	39.75	30.86	37.45	-
Other Long-Term Liabilities	165.67	105.54	92.02	68.93	55.36	0.18
Total Liabilities	1,640	1,524	1,187	451.63	207.61	57.13
Common Stock	2.4	2.38	2.38	2.09	2	1.55
Additional Paid-In Capital	-	2,643	2,591	2,460	2,133	1,275
Retained Earnings	-	-2,306	-1,836	-1,427	-918.6	-488.1
Comprehensive Income & Other	104.39	-5.23	9.31	-26.98	-6.09	-0.05
Total Common Equity	106.79	334.81	766.26	1,008	1,210	788.07
Minority Interest	-	-	-	-	45.81	-
Shareholders' Equity	106.79	334.81	766.26	1,008	1,256	788.07
Total Liabilities & Equity	1,747	1,859	1,953	1,460	1,464	845.2
Total Debt	1,008	979.13	739.2	222.81	4.79	6.07
Net Cash (Debt)	-210.99	-5.4	509.9	732.7	991.52	747.47
Net Cash Growth	-	-	-30.41%	-26.10%	32.65%	15.68%
Net Cash Per Share	-3.93	-0.10	9.62	14.41	22.10	20.23
Filing Date Shares Outstanding	54.01	53.67	53.67	52.34	49.94	38.71
Total Common Shares Outstanding	54.01	53.67	53.67	52.34	49.94	38.71
Working Capital	724.69	868.01	1,087	877.33	931.23	767.76
Book Value Per Share	1.98	6.24	14.28	19.26	24.24	20.36
Tangible Book Value	-364.88	-144.53	282.42	608.86	791.67	772.01
Tangible Book Value Per Share	-6.76	-2.69	5.26	11.63	15.85	19.94
Machinery	-	24.15	11.17	7.07	0.21	0.12

Source: S&P Capital IQ. Standard template. Financial Sources.